Literature DB >> 21660673

Review on efficacy and health services research studies of complementary and alternative medicine in inflammatory bowel disease.

Stefanie Joos1.   

Abstract

OBJECTIVE: To assess the evidence of the use and efficacy for complementary and alternative medicine (CAM) in inflammatory bowel disease (IBD).
METHODS: A systematic literature search in MEDLINE was performed for randomized controlled trials (RCTs) in Crohn's disease and ulcerative colitis. Moreover, a selective literature search for health services research studies on the use of CAM in patients with IBD was performed.
RESULTS: Health services research studies showed a high use of CAM in adult and pediatric patients with IBD worldwide. In contrast to the high use among IBD patients, there was a lack of high-quality data for many of the used CAM methods. Although most of the studies showed positive results, the methodological quality of most studies was rather low; therefore, the results had to be interpreted with caution. While there were many studies for probiotics and fish oil, RCTs for the highly used method homeopathy, for most herbal products, and for traditional Chinese medicine methods apart from acupuncture RCTs were completely lacking.
CONCLUSIONS: The lack of high-quality studies might be the consequence of the problems: associated with the funding of clinical trials involving CAM. However, having the high user rates in mind, high-quality studies assessing efficacy and safety of those methods are urgently needed. Furthermore, there is a quality need for better representation of CAM in undergraduate and postgraduate medical education.

Entities:  

Mesh:

Year:  2011        PMID: 21660673     DOI: 10.1007/s11655-011-0758-3

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  35 in total

1.  Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis.

Authors:  L Langmead; R M Feakins; S Goldthorpe; H Holt; E Tsironi; A De Silva; D P Jewell; D S Rampton
Journal:  Aliment Pharmacol Ther       Date:  2004-04-01       Impact factor: 8.171

2.  Remission induction and maintenance effect of probiotics on ulcerative colitis: a meta-analysis.

Authors:  Li-Xuan Sang; Bing Chang; Wen-Liang Zhang; Xiao-Mei Wu; Xiao-Hang Li; Min Jiang
Journal:  World J Gastroenterol       Date:  2010-04-21       Impact factor: 5.742

3.  Why patients with inflammatory bowel disease use or do not use complementary and alternative medicine: a Canadian national survey.

Authors:  Feng X Li; Marja J Verhoef; Allan Best; Anthony Otley; Robert J Hilsden
Journal:  Can J Gastroenterol       Date:  2005-09       Impact factor: 3.522

4.  Effects of Boswellia serrata gum resin in patients with ulcerative colitis.

Authors:  I Gupta; A Parihar; P Malhotra; G B Singh; R Lüdtke; H Safayhi; H P Ammon
Journal:  Eur J Med Res       Date:  1997-01       Impact factor: 2.175

5.  Acupuncture and moxibustion in the treatment of ulcerative colitis: a randomized controlled study.

Authors:  Stefanie Joos; Nicole Wildau; Ralf Kohnen; Joachim Szecsenyi; Detlef Schuppan; Stefan N Willich; Eckhart G Hahn; Benno Brinkhaus
Journal:  Scand J Gastroenterol       Date:  2006-09       Impact factor: 2.423

Review 6.  Probiotics for maintenance of remission in Crohn's disease.

Authors:  V E Rolfe; P J Fortun; C J Hawkey; F Bath-Hextall
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

7.  Evaluation of a psychological treatment for inflammatory bowel disease.

Authors:  S P Schwarz; E B Blanchard
Journal:  Behav Res Ther       Date:  1991

8.  Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.

Authors:  W Kruis; P Fric; J Pokrotnieks; M Lukás; B Fixa; M Kascák; M A Kamm; J Weismueller; C Beglinger; M Stolte; C Wolff; J Schulze
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

Review 9.  Fish oil for induction of remission in ulcerative colitis.

Authors:  M De Ley; R de Vos; D W Hommes; P Stokkers
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

10.  Use of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease.

Authors:  Stefanie Joos; Thomas Rosemann; Joachim Szecsenyi; Eckhart G Hahn; Stefan N Willich; Benno Brinkhaus
Journal:  BMC Complement Altern Med       Date:  2006-05-22       Impact factor: 3.659

View more
  7 in total

1.  An old herbal medicine with a potentially new therapeutic application in inflammatory bowel disease.

Authors:  Richard Li; Philip Alex; Mei Ye; Ting Zhang; Ling Liu; Xuhang Li
Journal:  Int J Clin Exp Med       Date:  2011-10-29

2.  A Probiotic for Ulcerative Colitis: The Culture Wars Continue.

Authors:  Bincy P Abraham; Eamonn M M Quigley
Journal:  Dig Dis Sci       Date:  2018-07       Impact factor: 3.199

Review 3.  Integrative Medicine for Gastrointestinal Disease.

Authors:  Michelle L Dossett; Ezra M Cohen; Jonah Cohen
Journal:  Prim Care       Date:  2017-06       Impact factor: 2.907

4.  'Someone should oversee it': patient perspectives on the ethical issues arising with the regulation of probiotics.

Authors:  Krista L Harrison; Ruth M Farrell; Margaret A Brinich; Janelle Highland; MaryBeth Mercer; Jennifer B McCormick; Jon Tilburt; Gail Geller; Patricia Marshall; Richard R Sharp
Journal:  Health Expect       Date:  2012-12-28       Impact factor: 3.377

Review 5.  Mechanism of Acupuncture and Moxibustion on Promoting Mucosal Healing in Ulcerative Colitis.

Authors:  Han Li; Xiao-Feng Ye; Yang-Shuai Su; Wei He; Jian-Bin Zhang; Qi Zhang; Li-Bin Zhan; Xiang-Hong Jing
Journal:  Chin J Integr Med       Date:  2022-04-12       Impact factor: 1.978

Review 6.  Herbal and plant therapy in patients with inflammatory bowel disease.

Authors:  Aikaterini Triantafyllidi; Theodoros Xanthos; Apostolos Papalois; John K Triantafillidis
Journal:  Ann Gastroenterol       Date:  2015 Apr-Jun

7.  Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study.

Authors:  Lena Oxelmark; Annelie Lindberg; Robert Löfberg; Berit Sternby; Anders Eriksson; Sven Almer; Ragnar Befrits; Bjöörn Fossum; Per Karlén; Olle Broström; Curt Tysk
Journal:  Eur J Gastroenterol Hepatol       Date:  2016-11       Impact factor: 2.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.